Biolatam is the biotechnology conference which provides unique access to Latin America, one of the fastest growing life science markets, in a forum for collaboration, discussion and partnering among key industry executives in Latin America, the US and Europe. International drug developers are increasingly targeting Latin America’s emerging market and innovative capabilities in generic pharmaceuticals, clinical trials and drug manufacturing. As well, governmental support for biotechnology companies has increased dramatically over the last decade, lending to a ripe environment for life science partnering.

$300 discount per delegate on prevailing rates for United Life Science members.

For more information and to register click here.